-
Determination of Apoptosis Sensitivity in Specific T Cell Subsets from Human Peripheral Blood by Uti
Among the different techniques available for determining physiological cell deat
2025-07-11 26 -
Determination of CD45 Tyrosine Phosphatase Activity in T Lymphocytes
CD45 is a leukocyte specific protein tyrosine phosphatase and is a major lymphoc
2025-07-11 33 -
Determination of Fc-Mediated Antibody-Effector Functions by Chromium Release Assay
Monoclonal antibodies (mAbs) can exert their biological functions by a large var
2025-07-11 32 -
Determination of HIV-1 Co-receptor Usage
Human immunodeficiency virus type I (HIV-1) infects target cells through interac
2025-07-11 32 -
Determination of HSV-1 Infectivity by Plaque Assay and a Luciferase Reporter Cell Line
Quantification of infectious virus is crucial to many experimental approaches in
2025-07-11 36 -
Determination of the Immunoreactivity of Radiolabeled Monoclonal Antibodies
Radiolabeled monoclonal antibodies (mAbs) are in use for numerous immunoassays a
2025-07-11 40 -
Determining Adjuvant Activity on T-Cell Function In Vivo: Th Cells
Adjuvants constitute a critical component in vaccine development in terms of bot
2025-07-11 41 -
Determining Alleles of the C2 Gene by Southern Blotting
The second component of human complement, C2, is a 102-kDa single-chain glycopro
2025-07-11 47 -
Determining FcRI Diffusional Dynamics via Single Quantum Dot Tracking
Single-particle tracking (SPT) using fluorescent quantum dots (QDs) provides hig
2025-07-11 27 -
Determining Ligand Specificity of Ly49 Receptors
Ly49 receptors in rodents, like KIR in humans, play an integral role in the regu
2025-07-11 35 -
Determining the Activity of Mucosal Adjuvants
Mucosal vaccination offers the advantage of blocking pathogens at the portal of
2025-07-11 27 -
Determining the Activity of the Transporter Associated with Antigen Processing in the Compartments o
Peptide-receptive MHC class I molecules and the TAP (transporter associated with
2025-07-11 25 -
Development and Activities of the BR96-Doxorubicin Immunoconjugate
The use of antibodies to selectively destroy tumors has attracted attention sinc
2025-07-11 32 -
Development and Characterization of Mouse Hybridomas
Cell fusion protocols that were developed by Kohler and Milstein in the mid-1970
2025-07-11 31 -
Development of a Mammalian Tet-On Expression Cell Line: Glucosylceramide Synthase Regulates TNF--Ind
Tumor necrosis factor-α (TNF-α) is one of the most pleiotropic of cytokines, act
2025-07-11 29
